PWP
TCRT icon

Private Wealth Partners’s Alaunos Therapeutics TCRT Stock Holding History

Private Wealth Partners’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-133
Closed -$113K – 122
2016
Q3 		$113K Hold
133
– – 0.03% 118
2016
Q2 		$110K Sell
133
-180
-58% -$196K 0.03% 122
2016
Q1 		$349K Sell
313
-48
-13% -$49.1K 0.08% 101
2015
Q4 		$450K Sell
361
-308
-46% -$509K 0.11% 98
2015
Q3 		$905K Buy
669
+462
+223% +$762K 0.23% 77
2015
Q2 		$372K Buy
+207
New +$321K 0.08% 110

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Private Wealth Partners's TCRT Position: Q4 2016 in Review

Private Wealth Partners sold out of Alaunos Therapeutics (TCRT) in Q4 2016, closing a stake of 133 shares — an estimated $113K sold.

Private Wealth Partners first reported a position in TCRT in Q2 2015 and held it in 6 quarters. The position peaked at $905K in Q3 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • Private Wealth Partners reported no remaining Alaunos Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Private Wealth Partners sold 133 Alaunos Therapeutics shares in Q4 2016, an estimated $113K.
  • Private Wealth Partners first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 6 quarters.
  • Private Wealth Partners's Alaunos Therapeutics position peaked at $905K in Q3 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on Private Wealth Partners's 13F filing for Q4 2016, filed 19 Jan 2017.